Table of Content
1 INDUSTRY OUTLOOK
1.1 Industry overview
1.2 Total addressable market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition - Infoholic Research
3.2 Basic Steps of Molecular diagnostics
3.3 Segmented Addressable Market (SAM)
3.4 Major Trends in the Molecular Diagnostics Market
3.5 Related Markets
3.5.1 Liquid Biopsy
3.5.2 Point-of-Care diagnostics
3.5.3 Immunoassays
3.5.4 Clinical Chemistry
4 Market Outlook
4.1 Evolution iof Molecular Diagnostics
4.2 Market segmentation
4.3 PEST Analysis
4.4 Porter 5(Five) Forces
5 Market Characteristics
5.1 DRO - Global Molecular Diagnostics Market Dynamics
5.1.1 Drivers
5.1.1.1 Rising Prevalence of Infectious Disease
5.1.1.2 Growing Adoption of Point-of-care Testing
5.1.1.3 Increasing Demand for Biomarker-based Tests
5.1.1.4 High Growth of the Market in Emerging Countries
5.1.2 Opportunities
5.1.2.1 Growing Significance of Companion Diagnostics
5.1.2.2 Increase in Number of Mergers and Acquisitions
5.1.2.3 Increased Adoption of DNA Probe-based Diagnostics
5.1.3 Restraints
5.1.3.1 Stringent Regulatory Approvals
5.1.3.2 Lack of Skilled Labors
5.2 DRO - Impact Analysis
5.3 Key Stakeholders
6 Technology: Market Size and Analysis
6.1 Overview
6.2 PCR
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4 Microarray
6.5 Hybridization
6.6 DNA sequencing
6.7 Others
7 Application: Market Size and Analysis
7.1 Overview
7.2 Oncology
7.2.1 Breast cancer
7.2.2 Colorectal cancer
7.2.3 Prostate cancer
7.2.4 Other cancers
7.3 Blood testing
7.4 Infectious Disease
7.5 Genetic Testing
7.6 Tissue Typing
7.7 Others
8 End Users: Market Size and Analysis
8.1 Overview
8.2 Hospitals
8.3 Reference Laboratories
8.4 Others
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.3 Overview: US Molecular Diagnostics Market
9.4 Major Trends in the US Molecular Diagnostics Market
9.5 DRO - US Molecular Diagnostics Market Dynamics
9.6 Technology: US molecular Diagnostics Market
9.7 Application: US Molecular Diagnostics Market
9.8 Key companies of US molecular diagnostics market
9.9 Europe
9.9.1 UK 58
9.9.2 Germany
9.10 Asia Pacific
9.10.1 India
9.10.2 China
9.10.3 Japan
9.11 Rest of the World
9.11.1 Brazil
9.11.2 Mexico
9.11.3 Africa
10 Competitive Landscape
10.1 Overview
11 Vendor Profiles
11.1 Danaher Corporation
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Revenue
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 ABBOTT LABORATORIES
11.3.1 Overview
11.3.2 Business Unit
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategy
11.4 Hologic Inc.
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Siemens Healthineers (Siemens AG)
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business focus
11.5.5 SWOT analysis
11.5.6 Business Strategy
12 Companies to Watch For
12.1 Qiagen N.V.
12.1.1 Overview
12.2 Bio-Rad Laboratories
12.2.1 Overview
12.3 Myriad Genetics Inc.
12.3.1 Overview
12.4 Thermo Fisher Scientific
12.4.1 Overview
12.5 bioMerieux S.A.
12.5.1 Overview
12.6 Beckton Dickinson and Company
12.6.1 Overview
12.7 Grifols S.A.
12.7.1 Overview
12.8 Sysmex Corporation
12.8.1 Overview
13 Annexure
13.1 Abbreviations